4 cells/ml medium/2 cm 2 well and incubated at 37°C for a day. Then, the culture medium was removed, 0.5 ml/well of the serum free medium including a test compound was added, the cultures were incubated at 37°C for 20 min, and thereafter labeled with 25 mCi/well each of [ 3 H]-TdR, [
H]-UR, or [
3 H]-Leu at 37°C for 60 min. The medium was removed, the cell layers were washed three times with 1 ml/well of cold phosphate buffered saline (PBS) (Ϫ), 0.5 ml/well of cold 5% trichloroacetic acid (TCA) was added, the mixtures were kept cool for 40 min, and the supernatant (acid-soluble fraction) was taken. The remainder was washed once with 1 ml/well of 5% TCA and dissolved in 0.5 ml/well of 0.5 N KOH by allowing it to stand at a room temperature for 40 min (acid-insoluble fraction).
Analytical Procedures An HPLC system (3520, SSC Co., Ltd., Tokyo) using a column (ODS-2151-A, 6fϫ150 mm, SSC Co., Ltd.) was developed with 30% MeOH/12 mM phosphate buffer (pH 2.4) at a flow rate of 2 ml/min at 40°C, and the elution was monitored at 250 nm. 1 and 2 was eluted at a retention time of 7 and 18 min, respectively. Rf values on TLC (Kieselgel 60 F 254 Art, 5715, Merck) of 1 were 0.57 (n-PrOH : H 2 O : 1 N NH 4 OHϭ 10 : 1 : 1) and 0.48 (n-BuOH : AcOH : H 2 Oϭ4 : 1 : 1). The Rf values of 2 were 0.61 (CHCl 3 : MeOHϭ5 : 1) and 0.57 (n-BuOH : MeOH : H 2 Oϭ5 : 1 : 2), and the spots on the TLC were detected with phosphomolybdate-H 2 SO 4 .
Preparative HPLC A reverse-phase column (Capcell Pack C 18 , 5 mm-100 Å, 20ϫ150 mm, Shiseido Co., Ltd., Japan) was used for separation employing the same conditions as the analytical HPLC system, except that the flow rate has 9.9 ml/min.
General UV spectra were recorded on a Hitachi U-3210 spectrophotometer and IR spectra on a Hitachi 260-10 spectrophotometer. NMR spectra were recorded on a JEOL-A500 NMR spectrometer at 500 MHz for 
Results and Discussion
The futalosine producing strain, Streptomyces sp. MK359-NF1 was cultured by shaking at 27°C for 7 d in 500-ml Erlenmeyer flasks each containing 110 ml of a medium composed of 3% starch, 0.2% yeast extract, 1.5% soybean meal, 0.3% NaCl, 0.05% MgSO 4 · 7H 2 O, 0.03% CaCO 3 , 0.0005% CuSO 4 · 5H 2 O, 0.0005% MnCl 2 · 4H 2 O, 0.0005% ZnSO 4 · 7H 2 O and water to volume (pH 7.0 before sterilization). Futalosine was isolated from the fermentation broth according to the procedures as shown in Fig. 1 .
The UV absorption maximum of futalosine (1) (Table 1) and heteronuclear multiple bond correlation (HMBC) experiment showed that futalosine was an analog of a nucleoside which was coupled to an isophtalic acid moiety. Analyses of the 1 H-1 H correlated spectroscopy (COSY) and HMBC spectra of 1 indicated that a methylene (d H 3.08, 3.12) at the C-6Ј position in the nucleoside was directly linked to one carbonyl group of the isophtalic acid, and that the other carboxyl group was free (Fig. 3) . The 1 H-NMR spectrum of 1 in dimethyl sulfoxide (DMSO)-d 6 showed no signals arising from exchangeable protons at C-6, N-1, 2Ј or 3Ј in the nucleoside moiety or from the carboxyl group (C-14) in the isophtalic acid moiety. In order to confirm the structure of 1, a methyl derivative (2) was prepared by the treatment of 1 with trimethylsilyldiazomethane. The NMR spectral data of 2 and 1-N-methylfutalosine methylester, which was obtained together with 2 by methylation of 1 in DMSO-d 6 (data not shown) supported the presence of the hypoxanthine ring and the free carboxyl group at C-14 of 1. The NMR spectra of a diacetyl derivative which was prepared by the treatment of 1 with acetic anhydride and pyridine revealed the presence of the hydroxyl groups at 2Ј and 3Ј positions. Moreover, difference nuclear Overhauser effects (NOEs) were observed between H-8 and H-1Ј, H-8 and H-2Ј, and H-2Ј and H-3Ј of 1 in D 2 O. This NOE data suggested the hydroxyl groups at 2Ј and 3Ј were attached to the same side in the sugar moiety. The coupling constants of the sugar moiety in 1 were similar to those of the ribose moiety in oxanosine. 1) But the stereochemistry of the sugar moiety remained to be determined. Thus, the planar structure of futalosine was determined as shown in Fig. 2 .
Compound 2 inhibited the growth of HeLa-S3 (IC 50 ϭ 19.5 mg/ml) in vitro in contrast to the weak activity of futalosine (IC 50 Ͼ100 mg/ml). Cell growth was determined using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) method and the inhibition caused by the samples was calculated as reported.
2) 2 at 10 mg/ml inhibited incorporation of 3 H-thymidine and 3 H-uridine but not 3 Hleucine into the acid-soluble fraction of HeLa-S3 cells, over a 60 min labeling period (Fig. 4) . 1 in contrast, hardly inhibited radiolabel incorporation even at a concentration as high as 100 mg/ml. The difference in the effect between the two compounds may be a reflection of their different affinities to nucleoside transporters, 3) although an effect on other intracellular metabolic processes is possible. Incorporation into the acid-insoluble fraction of 3 H-thymidine and 3 H-uridine were also inhibited by 2, which may reflect the lowered radioactivities in the acid-soluble pools in the cells treated with 2. Some inhibition by 2 of the incorporation 3 H-leucine into the acid-insoluble fraction, accompanied by the corresponding enhancement of the incorporation into the acid-soluble pool (134% of the control) may be due to inhibition of the polymerization step of protein synthesis. Additional experiments also showed that 2 was not a simple inhibitor of the nucleoside transporter; dipyridamole, an inhibitor of this process, was antagonistic to FUdR while 2 was rather synergistic to FUdR (data not shown). Furthermore, the first 20 s labeling in vitro of HeLa-S3 cells with 3 H-TdR at 25°C (regarded as the membrane transport of the nucleoside) was inhibited by 2 only 1/10 as strongly as was inhibited by dipyridamole when each was compared at 50% growth-inhibitory concentration for HeLa-S3 cells (data not shown).
No sign of acute toxicity for 1 and 2 was detectable at 150 mg/kg in mice (i.v.). 1 and 2 did not inhibit in vitro growth of any bacteria, fungi or yeast at 100 mg/ml. 
